TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer

tsRNA-49-73-Glu-CTC has the potential to serve as a novel molecular diagnostic biomarker for NSCLC and plays a significant role in the biological processes associated with NSCLC proliferation and migration.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-03-28
DOI
https://doi.org/10.1371/journal.pone.0320187
Citations
3
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer

Shenjie Zhong, Chenyu Li, Juan Chen, Xingyu Mu
3 citations
PLoS ONE
RNA modifications and cancer
2.42
article

TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer

Shenjie Zhong, Chenyu Li, Juan Chen, Xingyu Mu
article en
3 citations

Abstract

tsRNA-49-73-Glu-CTC has the potential to serve as a novel molecular diagnostic biomarker for NSCLC and plays a significant role in the biological processes associated with NSCLC proliferation and migration.

PLoS ONEVol. 20(3)
Qingdao University (CN)
Good health and well-being
Openalex Percentile: Top 12%
RNA modifications and cancer
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer — Shenjie Zhong, Chenyu Li, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS